Skip to main content

Author: Kathy Whitney

Study to explore myeloma treatment’s impact on heart

Feb. 5, 2015—Vanderbilt is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart.

Read more


Findings do not support chlorhexidine bathing in ICUs

Jan. 21, 2015—Vanderbilt University Medical Center researchers have found that bathing critically ill patients with disposable chlorhexidine cloths did not decrease the incidence of health care-associated infections when compared to less expensive nonantimicrobial cloths, according to a study appearing online in JAMA this week.

Read more


New drugs approved to fight idiopathic pulmonary fibrosis

Jan. 15, 2015—The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).

Read more


Gene regulators of circulating trans fatty acids identified

Dec. 18, 2014—High consumption of trans fatty acids (TFA) has been linked to increased risk of heart disease, stroke and even cancer.

Read more


Vanderbilt University Medical Center offers surgical option for form of pulmonary hypertension

Nov. 18, 2014—A copy repairman who couldn’t do his job anymore and was forced to take medical leave has returned to work. A woman who couldn’t walk from her car to her desk job has enough energy to redecorate her house. A 42-year-old mother who was too sick to care for her children and was discharged to...

Read more


VUSM students land Sarnoff Foundation awards

Nov. 13, 2014—Two Vanderbilt University School of Medicine students are among 11 individuals nationwide to receive Sarnoff Foundation Medical Student Research Fellowship awards for 2014-2015.

Read more


NIH grant spurs diabetic nephropathy research

Oct. 30, 2014—Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy.

Read more


Heart patient uses ICD experience to promote benefits of exercise

Oct. 16, 2014—Carrie Romero of Columbia, Tennessee, is running for her life. In 1997, when she was 28, Romero was diagnosed with dilated cardiomyopathy — a heart muscle disease that puts her at risk for sudden cardiac arrest (SCA).

Read more


Heart Institute celebrates implantation program success

Oct. 9, 2014—Vanderbilt Heart and Vascular Institute (VHVI) reached a significant milestone recently with the 100th implantation of the miniaturized HeartWare HVAD Pump, a left ventricular assist device (LVAD) that supports the heart.

Read more


Program focuses on heart health of cancer patients

Oct. 2, 2014—The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States.

Read more


VHVI screening brings heart care to young athletes

Oct. 2, 2014—Vanderbilt Heart and Vascular Institute (VHVI) recently hosted a cardiovascular health screening for participants in a nonprofit organization called the Enplay Foundation, for middle and high school athletes and their adult family members.

Read more


These Doctors Mean Business: Med school graduates contributing in non-clinical roles

Sep. 18, 2014—While patient care is an important part of the careers of the majority of Vanderbilt University School of Medicine graduates, some find that they can make the greatest leadership contributions in non-clinical roles. “The solid foundation that these graduates have received in the art and science of medicine allows them to function much more effectively...

Read more


VIEW MORE EVENTS >